Skip to Main Content

Rani Therapeutics Holdings, Inc. Class A Common Stock

RANI Real Time Price USD
N/A
N/A
N/A
...
...
Overview
Financials
Forecast
Insiders
Institutions
Government
Ownership
Income
Balance Sheet
Cash Flow
Revenue Breakdown

Recent trades of RANI by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard
RANI Stock Insider Trading Activity
Name
Type
Shares
Price
Shares Held
Date
Reported
RANI Stock Institutional Owners
Investor
Shares
Change in Shares
Market Value
Date
Reported
RANI Derivatives Institutional Owners
Investor
Type
Shares
Change in Shares
Market Value
Date
Reported

Recently reported changes by institutional investors

Quiver Logo

No Whale Activity for this ticker

Institutional Holdings Dashboard

Quarterly net insider trading by RANI's directors and management

Government lobbying spending instances

Quiver Logo

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard

Estimated quarterly lobbying spending

Quiver Logo

No Corporate Lobbying data for this ticker

Corporate Lobbying Dashboard

RANI Revenue by Segment or Geography

By Segment
By Geography
Quiver Logo

No Revenue by Segment data for this ticker

Revenue Breakdown Dashboard
Quiver Logo

No Revenue by Geography data for this ticker

Revenue Breakdown Dashboard
RANI Income Statement
RANI Balance Sheet
RANI Cash Flow
U.S. Patents

New patents grants

  • Patent Title: Device, system and methods for the oral delivery of therapeutic compounds Apr. 01, 2025
  • Patent Title: Pharmaceutical compositions and methods for fabrication of solid masses comprising polypeptides and/or proteins Feb. 04, 2025
  • Patent Title: Clotting factor preparations for delivery into tissue of the intestinal tract using a swallowable drug delivery device Jan. 21, 2025
  • Patent Title: Ingestible device with expandable enclosure Oct. 29, 2024
  • Patent Title: Pcsk9 antibody preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device Jun. 25, 2024
  • Patent Title: Method of delivering insulin into a lumen of the intestinal tract using a swallowable drug delivery device Dec. 19, 2023
  • Patent Title: Propulsive drug delivery from a swallowable device into a patients intestinal tract Dec. 05, 2023
  • Patent Title: Clotting factor preparations for delivery into tissue of the intestinal tract using a swallowable drug delivery device Nov. 28, 2023
  • Patent Title: Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device Nov. 14, 2023
  • Patent Title: Method of delivering a somatostatin compound into a lumen of the intestinal tract using a swallowable drug delivery device Nov. 14, 2023
  • Patent Title: Device, system and methods for the oral delivery of therapeutic compounds Nov. 07, 2023
  • Patent Title: Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device Oct. 03, 2023
  • Patent Title: Pharmaceutical compositions and methods for fabrication of solid masses comprising polypeptides and/or proteins Aug. 08, 2023
  • Patent Title: Preparation comprising exanatide for delivery into a lumen of the intestinal tract Jun. 27, 2023
  • Patent Title: Method of delivering gonadotropin releasing hormone or an analogue thereof into a lumen of the intestinal tract using a swallowable drug delivery device May. 23, 2023
  • Patent Title: Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device May. 02, 2023
  • Patent Title: Devices, systems, and methods for delivering therapeutic agents into a stomach wall Jan. 31, 2023
  • Patent Title: Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device Jan. 17, 2023
  • Patent Title: Anti-interleukin antibody preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device Jan. 10, 2023
  • Patent Title: Clotting factor preparations for delivery into tissue of the intestinal tract using a swallowable drug delivery device Oct. 11, 2022
  • Patent Title: Methods for delivering etanercept preparations into a lumen of the intestinal tract using a swallowable drug delivery device Aug. 23, 2022
  • Patent Title: Therapeutic agent preparations into a lumen of the intestinal tract using a swallowable drug delivery device Jul. 05, 2022
  • Patent Title: Swallowable drug delivery device and methods of drug delivery May. 24, 2022
  • Patent Title: Pharmaceutical compositions and methods for fabrication of solid masses comprising polypeptides and/or proteins Apr. 19, 2022
  • Patent Title: Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device Apr. 19, 2022
  • Patent Title: Pharmaceutical compositions and methods for fabrication of solid masses comprising tnf-inhibiting antibodies Apr. 05, 2022
  • Patent Title: Swallowable drug delivery device and methods of drug delivery Feb. 22, 2022
  • Patent Title: Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device Jan. 25, 2022
  • Patent Title: Swallowable capsule, system and method for measuring gastric emptying parameters Aug. 31, 2021
  • Patent Title: Shaped mass composition comprising exenatide Jun. 08, 2021
  • Patent Title: Swallowable drug delivery device and method of delivery Apr. 27, 2021
  • Patent Title: Therapeutic preparation comprising insulin for delivery into a lumen of the intestinal tract using a swallowable drug delivery device Apr. 20, 2021
  • Patent Title: Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device Apr. 06, 2021
  • Patent Title: Method of delivering a somatostatin compound into a lumen of the intestinal tract using a swallowable drug delivery device Mar. 23, 2021
  • Patent Title: Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device Feb. 23, 2021
  • Patent Title: Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device Jan. 12, 2021
  • Patent Title: Preparation comprising exanatide for delivery into a lumen of the intestinal tract Dec. 29, 2020
  • Patent Title: Method of delivering gonadotropin releasing hormone or an analogue thereof into a lumen of the intestinal tract using a swallowable drug delivery device Dec. 15, 2020
  • Patent Title: Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device Aug. 25, 2020
  • Patent Title: Methods for delivering etanercept preparations into a lumen of the intestinal tract using a swallowable drug delivery device May. 05, 2020
  • Patent Title: Therapeutic agent preparations into a lumen of the intestinal tract using a swallowable drug delivery device Mar. 24, 2020
  • Patent Title: Therapeutic composition comprising insulin prepared for delivery into an intestinal tract Feb. 04, 2020
  • Patent Title: Therapeutic agent preparations into a lumen of the intestinal tract using a swallowable drug delivery device Dec. 03, 2019
  • Patent Title: Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device Nov. 26, 2019
  • Patent Title: Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device Nov. 19, 2019
  • Patent Title: Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device Jul. 16, 2019
  • Patent Title: Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device Jul. 02, 2019
  • Patent Title: Method of delivering gonadotropin releasing hormone or an analogue thereof into a lumen of the intestinal tract using a swallowable drug delivery device Jun. 18, 2019
  • Patent Title: Method of delivering a somatostatin compound into a lumen of the intestinal tract using a swallowable drug delivery device Jun. 11, 2019
  • Patent Title: Method for delivering pramlintide into a lumen of the intestinal tract using a swallowable drug delivery device Jun. 11, 2019
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard
Government Contracts

Estimated quarterly amount awarded from public contracts

Quiver Logo

No recent Government Contracts for this ticker

Government Contracts Dashboard
RANI News

Recent insights relating to RANI

CNBC Recommendations

Recent picks made for RANI stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in RANI

RANI Analyst Ratings

RANI Stock Forecasts
...

  • ... Highest Price Target
  • ... Median Price Target
  • ... Lowest Price Target
RANI Analyst Forecasts
Analyst
Firm
Current
Previous
Date
Frequently Asked Questions
  • Is $RANI stock a Buy, Sell, or Hold?

  • What is the price target for $RANI stock?

* Analyst consensus is not financial advice. Please see our data disclaimers .

RANI Top Shareholders
Shareholder
Shares Held
RANI Options Owners
Shareholder
Security
Underlying Shares
Frequently Asked Questions
  • Who owns $RANI stock?

  • Who owns the most shares of $RANI stock?

  • What funds own $RANI stock?

* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.

RANI Stock Smart Score

The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.

The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?

Sign Up to view RANI Smart Score

Score Breakdown
Bull Case vs Bear Case

See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.

Example:

Bulls Say:

The Bulls Say summary highlights positive aspects of the stock.

Bears Say:

The Bears Say summary points out potential risks and negative aspects of the stock.

Show More
Back To Top